After Big Win in Court, CMS Proposes Cutting 340B Drug Payments Even More
Fresh off a major federal appeals court win, the U.S. Centers for Medicare & Medicaid Services (CMS) proposed this morning to cut Medicare Part B payments
…Category: Regulatory
Could CMS Follow Up 340B Court Victory with Deeper Cuts for Hospitals?
Yesterday’s federal appeals court ruling upholding the Trump administration’s nearly 30 percent cut in 340B hospitals’ Medicare Part B drug reimbursement raises the question of what to expect
…BREAKING: U.S. Appeals Court Upholds Deep Cuts in 340B Hospitals’ Medicare Part B Drug Reimbursement
U.S. Appeals Court Upholds Deep Cuts in 340B Hospitals’ Medicare Part B Drug Reimbursement
The Trump administration’s nearly 30 percent cut since 2018 in 340B hospitals’ drug reimbursement under the hospital outpatient prospective payment system
…Breaking News
BREAKING: Health Centers Challenge Administration Suggestions They Put 340B Profits Over Patients
Health Centers Challenge Administration Suggestions They Put 340B Profits Over Patients
The nation’s community health centers last night struck back against a presidential executive order and Trump administration comments that
…Breaking News
BREAKING: Presidential Executive Order Targets 340B Health Centers’ Savings on Insulin and EpiPen
Presidential Executive Order Targets 340B Health Center’ Savings on Insulin and EpiPen
Update, 9:50 p.m. EDT, July 24—National Association of Community Health Centers President and CEO Tom Van Coverden issued
…Pedley: HRSA’s Power to Enforce 340B Guidance is Limited
Testoni: Some in Pharma Want to Make 340B a Rebate Program
The federal official in charge of the 340B program today said again that although the U.S.
…A Message from Publisher and CEO Ted Slafsky: We are excited that the 340B Coalition Conference has started and 340B Report will be sending out a special edition later today covering the remarks of Rear Admiral Krista
…Hospitals and Other Providers Ask HHS to Halt Lilly and Merck’s Clampdowns on 340B; Companies Defend Their Positions
The U.S. Health and Human Services Department (HHS) should halt drug manufacturers Eli Lilly and Merck’s recent separate actions to curtail or
…A Message from Publisher and CEO Ted Slafsky: Happy Tuesday from sunny Washington, D.C.! I encourage you to read Comprehensive Pharmacy Services’ (CPS) article about its new white paper on navigating the 340B program during the COVID-19
…